Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bayard L. Powell, MD
Wake Forest University Health Sciences
- Istvan Molnar, MD
Wake Forest University Health Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Regional Radiation Oncology Center at Rome
Rome, Georgia, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Kentuckiana Cancer Institute, Pllc
Louisville, Kentucky, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Alamance Cancer Center
Burlington, North Carolina, United States
- Hugh Chatham Memorial Hospital
Elkin, North Carolina, United States
- Southeastern Medical Oncology Center
Goldsboro, North Carolina, United States
- Brody School of Medicine at East Carolina University
Greenville, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Cancer Centers of the Carolinas - Eastside
Greenville, South Carolina, United States
- Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2003
- Primary completion
- 30 Apr 2006
- Completion
- 31 Dec 2007
- Last update posted
- 19 Jan 2017
- Registered enrollment
- —
- Registry id
- NCT00072579
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.